Xingfeng Qiu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Inflammasome and immune disorders
Papers in
-
- Cell death mechanisms and regulation 5
- Epigenetics and DNA Methylation 4
- Histone Deacetylase Inhibitors Research 3
- Ubiquitin and proteasome pathways 3
- Oncology 9
- Colorectal Cancer Screening and Detection 4
- Colorectal Cancer Surgical Treatments 3
- Co-authors
- Xuehui Hong (8 shared papers)Yuekun Zhu (6 shared papers)Jiahuai Han (2 shared papers)Mengya Zhong (5 shared papers)Yaoji Liang (1 shared paper)Zhiyu Cai (1 shared paper)Jianfeng Wu (1 shared paper)Min Liu (1 shared paper)
- Journals
- Oncogene (2 papers)Autophagy (1 paper)Journal of Colloid and Interface Science (1 paper)International Journal of Surgery (1 paper)Cell Death and Disease (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xingfeng Qiu
22 papers receiving 677 citations
Peers
Comparison fields: 5 of 74
- Cancer Research 160
- Molecular Biology 521
- Immunology 158
- Oncology 141
- Physiology 19
Countries citing papers authored by Xingfeng Qiu
This map shows the geographic impact of Xingfeng Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingfeng Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingfeng Qiu more than expected).
Fields of papers citing papers by Xingfeng Qiu
This network shows the impact of papers produced by Xingfeng Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingfeng Qiu. The network helps show where Xingfeng Qiu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xingfeng Qiu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 212 | |
| 2 | 2019 | 89 | |
| 3 | 2017 | 63 | |
| 4 | 2019 | 61 | |
| 5 | 2018 | 39 | |
| 6 | 2016 | 39 | |
| 7 | 2020 | 34 | |
| 8 | 2020 | 33 | |
| 9 | 2020 | 26 | |
| 10 | 2020 | 24 | |
| 11 | 2020 | 14 | |
| 12 | 2019 | 13 | |
| 13 | 2016 | 10 | |
| 14 | 2025 | 8 | |
| 15 | 2021 | 7 | |
| 16 | 2016 | 5 | |
| 17 | [Transumbilical single-port access laparoscopic surgery for colorectal cancer]. | 2011 | 2 |
| 18 | [Expression of inductive nitric oxide synthase and vascular endothelial growth factor in colonic carcinoma, and their effects on tumor angiogenesis]. | 2005 | 2 |
| 19 | 2017 | 1 | |
| 20 | 2023 | 1 |
About Xingfeng Qiu
Xingfeng Qiu is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 24 papers that have together received 685 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (5 papers), Epigenetics and DNA Methylation (4 papers), Colorectal Cancer Screening and Detection (4 papers), Gastric Cancer Management and Outcomes (4 papers), Colorectal Cancer Surgical Treatments (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Ubiquitin and proteasome pathways (3 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (160 citations), Molecular Biology (521 citations), Immunology (158 citations), Oncology (141 citations) and Physiology (19 citations). Xingfeng Qiu has collaborated with scholars based in China and United States. Frequent co-authors include Xuehui Hong, Yuekun Zhu, Jiahuai Han, Mengya Zhong, Yaoji Liang, Zhiyu Cai, Jianfeng Wu, Min Liu, Hui Chen and Xing Feng. Their work appears in journals such as Oncogene, Autophagy, Journal of Colloid and Interface Science, International Journal of Surgery and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.